NA
Neha Arora
About Neha Arora
Data last updated:
Neha Arora is a Director at Sky Vision Pharma Private Limited (since 2021). The companies operate in Manufacturing. Sky Vision Pharma Private Limited reported revenue of ₹1.82 Cr (FY 2025). Earlier, Neha Arora was a Director at Indore Diagnostic And Imaging Healthcare Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sky Vision Pharma Private Limited U24239MP2021PTC071972 | Director | 05 Apr 2021 | 2021 | ₹1.82 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Indore Diagnostic And Imaging Healthcare Private Limited U85100MP2021PTC056246 | Director | 09 Jun 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Neha Arora
| Name | DIN | Company | Designation |
|---|---|---|---|
| Damini Devlalikar | 09134383 | Sky Vision Pharma Private Limited | Director |
| Isha Singh | 09134162 | Sky Vision Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neha Arora
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neha Arora
Neha Arora currently holds 1 directorship: Sky Vision Pharma Private Limited (Director, since 05 Apr 2021, revenue ₹1.82 Cr (FY 2025)).
Neha Arora was first appointed on 05 Apr 2021 as Director at Sky Vision Pharma Private Limited.
Neha Arora held 1 earlier board appointment: Indore Diagnostic And Imaging Healthcare Private Limited (Director, from 09 Jun 2021).
The current boards of Neha Arora's companies include Damini Devlalikar (Sky Vision Pharma Private Limited), Isha Singh (Sky Vision Pharma Private Limited).